Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 12,834.1%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,834.13% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 2,698.12% |
Abivax SA American Depositary Shares (ABVX) | 1,209.94% |
TMC the metals (TMC) | 503.51% |
Celcuity LLC (CELC) | 463.09% |
Centrus Energy (LEU) | 432.78% |
Sandisk (SNDK) | 403.39% |
Opendoor Technologies (OPEN) | 390.46% |
GRAIL, LLC (GRAL) | 376.99% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 354.75% |
ViaSat (VSAT) | 344.66% |
Applied Digital (APLD) | 337.58% |
Cipher Mining (CIFR) | 324.38% |
Uniqure (QURE) | 280.5% |
Cidara Therapeutics (CDTX) | 268.79% |
Energy Fuels (UUUU) | 263.81% |
Navitas Semiconductor (NVTS) | 250.55% |
Ramaco Resources (METC) | 234.25% |
Mineralys Therapeutics, Inc Common Stock (MLYS) | 228.95% |
Planet Labs PBC (PL) | 225.43% |
Sibanye Gold Ltd ADR (SBSW) | 215.25% |
SSR Mining (SSRM) | 214.91% |
Quantumscape (QS) | 210.1% |
Pagaya Technologies (PGY) | 205.05% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
